My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zentalis Pharmaceuticals, Inc. - common stock (NQ:ZNTL)

1.590 -0.030 (-1.85%)
Streaming Delayed Price Updated: 2:16 PM EDT, Oct 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 477,173
Open 1.600
Bid (Size) 1.590 (54)
Ask (Size) 1.600 (84)
Prev. Close 1.620
Today's Range 1.560 - 1.630
52wk Range 1.010 - 4.440
Shares Outstanding 45,052,904
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Zentalis (ZNTL) Q2 Loss Narrows 70%
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga

Performance

YTD
-47.0%
-47.0%
1 Month
+9.7%
+9.7%
3 Month
+16.9%
+16.9%
6 Month
+30.3%
+30.3%
1 Year
-46.3%
-46.3%

More News

Read More
Here are the top movers in Wednesday's session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
(ZNTL) - Analyzing Zentalis Pharma's Short Interest
Via Benzinga
Analyst Expectations for Zentalis Pharma's Future
Via Benzinga
These stocks that are showing activity before the opening bell on Wednesday.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
FDA Removes Partial Hold On Zentalis Pharmaceuticals' Azenosertib Studies In Patients With Gynecological Cancers
Via Benzinga
Newman Ferrara LLP Announces Corporate Governance Investigation of Zentalis Pharmaceuticals, Inc. – ZNTL
From Newman Ferrara LLP
Via Business Wire
Zentalis Pharmaceuticals, Inc. (ZNTL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
ZNTL Stock Earnings: Zentalis Pharma Misses EPS for Q2 2024
Via InvestorPlace
ZNTL Investors Have Opportunity to Join Zentalis Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, June 22
Via Talk Markets
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
ZNTL Stock Earnings: Zentalis Pharma Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
Via Talk Markets
Immunome Exclusively Licenses Zentalis ROR1 Antibody-Drug Conjugate and Proprietary Technology Platform
From Immunome, Inc.
Via Business Wire

Frequently Asked Questions

Is Zentalis Pharmaceuticals, Inc. - common stock publicly traded?
Yes, Zentalis Pharmaceuticals, Inc. - common stock is publicly traded.
What exchange does Zentalis Pharmaceuticals, Inc. - common stock trade on?
Zentalis Pharmaceuticals, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock?
The ticker symbol for Zentalis Pharmaceuticals, Inc. - common stock is ZNTL on the Nasdaq Stock Market
What is the current price of Zentalis Pharmaceuticals, Inc. - common stock?
The current price of Zentalis Pharmaceuticals, Inc. - common stock is 1.590
When was Zentalis Pharmaceuticals, Inc. - common stock last traded?
The last trade of Zentalis Pharmaceuticals, Inc. - common stock was at 10/14/25 02:16 PM ET
What is the market capitalization of Zentalis Pharmaceuticals, Inc. - common stock?
The market capitalization of Zentalis Pharmaceuticals, Inc. - common stock is 71.63M
How many shares of Zentalis Pharmaceuticals, Inc. - common stock are outstanding?
Zentalis Pharmaceuticals, Inc. - common stock has 72M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.